Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Market Cap	1.64B
Revenue (ttm)	489.33M
Net Income (ttm)	5.11M
Shares Out	20.80M
EPS (ttm)	0.24
PE Ratio	321.55
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	250,290
Average Volume	102,747
Open	77.47
Previous Close	79.04
Day's Range	75.96 - 82.73
52-Week Range	52.35 - 90.98
Beta	0.38
RSI	77.70
Earnings Date	May 23, 2025

About NSE:LOTUSEYE

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE lasik, touch free laser, lasik eye surgery, epilasik, intralase, supracor, robotic femto laser cataract surgery, phacoemulsification, paediatric eye care and squint surgery, and micro incision cataract surgery treatments. It also provides epizyoptix, special kertometer, and synaptophore; SICS, Phaco, MICS, LRCS, SFLOL, and SF IOL cataract surgery; corneal patchgraft, scleral repair, scrapping +...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1989
• Employees: 336
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: LOTUSEYE

Financial Performance

In 2023, NSE:LOTUSEYE's revenue was 482.10 million, an increase of 2.48% compared to the previous year's 470.44 million. Earnings were 29.15 million, a decrease of -28.52%.